Extracted data fields included: study design, sample size, patient demographics, heart failure diagnostic criteria, intervention details (type and dosage of SGLT2 inhibitor), comparator characteristics, duration of follow-up, primary and secondary outcomes, and study quality assessment using the Cochrane Risk of Bias tool. Here, SLC5A2 is linked to heart failure.